SMTL ID : 5sci.1 (1 other biounit)

Structure of liver pyruvate kinase in complex with anthraquinone derivative 105

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

homo-tetramer

Ligands

4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)

FBP.1: 16 residues within 4Å: Chain A: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 20 PLIP interactions: 20 interactions with chain A Hydrogen bonds: A:T.348, A:T.349, A:T.350, A:G.351, A:S.353, A:S.353, A:G.430, A:R.432, A:R.432, A:G.434, A:S.435, A:G.436, A:Y.437 Water bridges: A:T.349, A:T.349, A:R.371, A:W.398, A:R.405, A:T.438 Salt bridges: A:R.405 FBP.5: 16 residues within 4Å: Chain B: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 20 PLIP interactions: 20 interactions with chain B Hydrogen bonds: B:T.348, B:T.349, B:T.349, B:T.350, B:G.351, B:S.353, B:S.353, B:G.430, B:R.432, B:R.432, B:G.434, B:G.436, B:Y.437 Water bridges: B:R.371, B:R.371, B:D.401, B:R.405, B:R.405, B:R.405 Salt bridges: B:R.405 FBP.9: 17 residues within 4Å: Chain C: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, T.429, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 18 PLIP interactions: 18 interactions with chain C Hydrogen bonds: C:T.348, C:T.348, C:T.349, C:T.350, C:G.351, C:S.353, C:S.353, C:G.430, C:R.432, C:R.432, C:G.434, C:G.436, C:Y.437 Water bridges: C:T.349, C:T.349, C:R.405, C:R.405 Salt bridges: C:R.405 FBP.14: 16 residues within 4Å: Chain D: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 24 PLIP interactions: 24 interactions with chain D Hydrogen bonds: D:T.348, D:T.349, D:T.350, D:G.351, D:S.353, D:S.353, D:G.430, D:R.432, D:G.434, D:S.435, D:G.436, D:Y.437, D:Y.437 Water bridges: D:L.347, D:T.349, D:T.349, D:R.371, D:R.405, D:R.405, D:R.405, D:R.405, D:G.430, D:T.438 Salt bridges: D:R.405

4 x OXL: OXALATE ION(Non-covalent)

OXL.2: 8 residues within 4Å: Chain A: K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.3 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:G.211, A:D.212, A:T.244, A:T.244, A:T.244 Salt bridges: A:R.87, A:K.186, A:K.186 OXL.6: 9 residues within 4Å: Chain B: R.87, K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.7 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:G.211, B:D.212, B:D.212, B:D.212 Salt bridges: B:R.87, B:K.186 OXL.10: 9 residues within 4Å: Chain C: R.87, K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.11 6 PLIP interactions: 6 interactions with chain C Hydrogen bonds: C:E.188, C:G.211, C:D.212 Salt bridges: C:R.87, C:K.186, C:K.186 OXL.15: 9 residues within 4Å: Chain D: R.87, K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.16 9 PLIP interactions: 9 interactions with chain D Hydrogen bonds: D:E.188, D:G.211, D:D.212, D:D.212, D:T.244, D:T.244, D:T.244 Salt bridges: D:R.87, D:K.186

4 x MG: MAGNESIUM ION(Non-covalent)

MG.3: 3 residues within 4Å: Chain A: E.188, D.212 Ligands: OXL.2 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:E.188, A:D.212 MG.7: 3 residues within 4Å: Chain B: E.188, D.212 Ligands: OXL.6 3 PLIP interactions: 2 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:E.188, B:D.212, H2O.6 MG.11: 4 residues within 4Å: Chain C: K.186, E.188, D.212 Ligands: OXL.10 4 PLIP interactions: 3 interactions with chain C, 1 Ligand-Water interactions Metal complexes: C:E.188, C:E.188, C:D.212, H2O.10 MG.16: 3 residues within 4Å: Chain D: E.188, D.212 Ligands: OXL.15 2 PLIP interactions: 2 interactions with chain D Metal complexes: D:E.188, D:D.212

4 x K: POTASSIUM ION(Non-covalent)

K.4: 6 residues within 4Å: Chain A: N.89, S.91, D.127, T.128, S.159, K.186 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:S.91, A:D.127, A:T.128 K.8: 6 residues within 4Å: Chain B: N.89, S.91, D.127, T.128, S.159, K.186 3 PLIP interactions: 3 interactions with chain B Metal complexes: B:S.91, B:D.127, B:T.128 K.12: 6 residues within 4Å: Chain C: N.89, S.91, D.127, T.128, S.159, K.186 3 PLIP interactions: 3 interactions with chain C Metal complexes: C:S.91, C:D.127, C:T.128 K.17: 6 residues within 4Å: Chain D: N.89, S.91, D.127, T.128, S.159, K.186 3 PLIP interactions: 3 interactions with chain D Metal complexes: D:S.91, D:D.127, D:T.128

1 x I9F: dimethyl (2R)-2-hydroxy-2-{2-[4-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperazin-1-yl]-2-oxoethyl}butanedioate(Non-covalent)

I9F.13: 14 residues within 4Å: Chain C: T.64, P.67, R.87, N.89, S.91, H.92, G.93, Y.97, H.98, D.212, S.278, G.279, A.282, K.283 9 PLIP interactions: 9 interactions with chain C Hydrophobic interactions: C:P.67, C:N.89, C:Y.97, C:A.282 Hydrogen bonds: C:R.87, C:N.89, C:K.283 Water bridges: C:G.279 pi-Cation interactions: C:H.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nain-Perez, A. et al., Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase. Eur.J.Med.Chem. (2022)

Release Date

2022-03-16

Peptides

Pyruvate kinase: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Pyruvate kinase

Related Entries With Identical Sequence